Sign up USA
Proactive Investors - Run By Investors For Investors

Q BioMed announces favourable amendment to debenture financing

The new maturity date has been extended to November 30, 2018
Q BioMed announces favourable amendment to debenture financing
Q BioMed’s CEO, Denis Corin said: “We are pleased that this deal has worked out well for them and us and we will continue to work with them to secure the best outcome for both them and the rest of our shareholders.”

Q BioMed Inc (OTCMKTS:QBIO) said its funding partner, Yorkville Advisors has agreed to extend the maturity date on its US$2mln balance of the convertible note by one year.

The new maturity date has been pushed to November 30, 2018.

READ: Q BioMed says cancer pain drug will be available later this month

On November 29, last year, the biotech acceleration company entered into a securities purchase deal with Yorkville Advisors to place convertible debentures with a one-year term for US$4mln, with a 5% interest.

Q BioMed’s CEO, Dens Corin said: “We are pleased that this deal has worked out well for them and us and we will continue to work with them to secure the best outcome for both them and the rest of our shareholders.”

View full QBIO profile View Profile

Q BioMed Inc Timeline

Related Articles

numerous pills
March 23 2018
Genervon is on the lookout for pharma partners to help advance its GM6 drug, which takes aim at a range of deadly diseases hitting the central nervous system
1511901712_biotech_517925923.jpg
November 29 2017
The company has developed a "unique and superior pressure" cycling technology (PCT), says Zacks.
couple looking at pregnancy test
November 13 2017
The proceeds from the fundraiser will be used to expand in the People's Republic and will invested in product development
Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use